DL-erythro-Dihydrosphingosine is a sphingosine-based PKC inhibitor. DL-erythro-Dihydrosphingosine directly inhibits the enzymatic activity of PLA2. DL-erythro-Dihydrosphingosine inhibits the activity of Bcl-2 protein involved in apoptosis. DL-erythro-Dihydrosphingosine inhibits the activity of matrix metalloproteinases (MMPs). DL-erythro-Dihydrosphingosine is applicable for research on cancer and inflammatory diseases[1][2].
Molekulargewicht:
301.52
Reinheit:
98
CAS Nummer:
[3102-56-5]
Formel:
C18H39NO2
Target-Kategorie:
Apoptosis,Bcl-2 Family,MMP,Phospholipase,PKC
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten